SS Innovations International (SSII) Cash & Equivalents (2016 - 2026)
SS Innovations International (SSII) reported Cash & Equivalents of $16.0 million for Q1 2026, up 0.67% on a YoY basis from $15.9 million in Q1 2025, and up 398.37% sequentially from $3.2 million in Q4 2025.
SS Innovations International (SSII) Cash & Equivalents (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Cash & Equivalents data on file, last reported at $16.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 0.67% year-over-year to $16.0 million; the trailing twelve-month figure through Mar 2026 stood at $16.0 million (up 0.67% YoY), and the FY2025 full-year result was $3.2 million, up 587.33% from the prior year.
- Cash & Equivalents rose to $16.0 million in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $16.0 million in Q1 2026 to a low of $217177.0 in Q4 2022.
- A 5-year average of $3.8 million and a median of $608215.0 in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents slumped 96.66% in 2024 and surged 2478.39% in 2025, its largest moves.
- Tracing SSII's Cash & Equivalents over 5 years: stood at $217177.0 in 2022, then jumped by 831.16% to $2.0 million in 2023, then slumped by 76.93% to $466500.0 in 2024, then jumped by 587.33% to $3.2 million in 2025, then surged by 398.37% to $16.0 million in 2026.
- Business Quant data shows SSII's Cash & Equivalents at $16.0 million in Q1 2026, $3.2 million in Q4 2025, and $5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 15.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.98 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 11.38 Mn |
| Mar 31, 2025 | 15.87 Mn |
| Dec 31, 2024 | 466,500.00 |
| Sep 30, 2024 | 220,357.00 |
| Jun 30, 2024 | 608,215.00 |
| Mar 31, 2024 | 948,119.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 423,062.00 |
| Mar 31, 2023 | 448,543.00 |
| Dec 31, 2022 | 217,177.00 |
| Sep 30, 2022 | 514,143.00 |
| Jun 30, 2022 | 261,089.00 |
| Mar 31, 2022 | 346,869.00 |
| Dec 31, 2021 | 405,774.00 |
| Sep 30, 2021 | 205,195.00 |
| Jun 30, 2021 | 307,565.00 |